For the third time, the US Federal Trade Commission has sent warning letters to drug companies, disputing improperly listed patents in the US Food and Drug Administration’s Orange Book. The agency tar
For the third time, the Federal Trade Commission has sent out warning letters to drug companies, disputing improperly listed patents in the US Food and Drug Administration’s Orange Book. In this round
Aurobindo and MSN Labs are facing a wait of more than a decade to launch their proposed generic versions of Acadia Pharmaceuticals ’ Nuplazid (pimavanserin tartrate) 34mg capsules after a US feder
Teva is aiming to build a long-acting injectable schizophrenia franchise worth between $1.5bn and $2bn in annual sales at its peak, bolstered by a high unmet need and poor adherence for oral medicatio